3.23
price down icon6.38%   -0.22
after-market Handel nachbörslich: 3.28 0.05 +1.55%
loading

Pyxis Oncology Inc Aktie (PYXS) Neueste Nachrichten

pulisher
Oct 14, 2025

What makes Pyxis Oncology Inc. stock attractive to growth fundsQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Pyxis Oncology (PYXS) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Oct 14, 2025
pulisher
Oct 14, 2025

5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Yahoo Finance

Oct 14, 2025
pulisher
Oct 14, 2025

Why Pyxis Oncology Inc. stock is a value investor pickWeekly Stock Analysis & Risk Managed Investment Strategies - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Will Pyxis Oncology Inc. stock continue upward momentumMarket Growth Report & Community Consensus Picks - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Strategies to average down on Pyxis Oncology Inc.2025 Growth vs Value & Reliable Breakout Forecasts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Pyxis Oncology to Present Translational Data and Key - GlobeNewswire

Oct 13, 2025
pulisher
Oct 13, 2025

ctDNA reduction in 37 clinical samples: Pyxis Oncology presents MICVO translational findings at ESMO & AACR 2025 - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

Smart tools for monitoring Pyxis Oncology Inc.’s price action2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Can Pyxis Oncology Inc. stock beat analyst upgradesTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How risky is Pyxis Oncology Inc. stock nowJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will Pyxis Oncology Inc. stock deliver better than expected guidance2025 Price Targets & Entry Point Confirmation Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Full technical analysis of Pyxis Oncology Inc. stockJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Developing predictive dashboards with Pyxis Oncology Inc. data2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Pyxis Oncology Gains 70%, Insider Trades Reap Benefit - 富途牛牛

Oct 10, 2025
pulisher
Oct 10, 2025

Pyxis Oncology (NASDAQ:PYXS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Will Pyxis Oncology Inc. see short term momentumVolume Spike & Pattern Based Trade Signal System - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Pyxis Oncology Inc. stock undervalued vs historical averages2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Pyxis Oncology Inc. stock a top pick in earnings seasonRate Cut & AI Enhanced Trading Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Real time pattern detection on Pyxis Oncology Inc. stockMarket Growth Report & Community Consensus Picks - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Pyxis Oncology, Inc. Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets, Effective October 9, 2025 - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Pyxis Oncology appoints Alex Kane as SVP of investor relations By Investing.com - Investing.com Australia

Oct 09, 2025
pulisher
Oct 09, 2025

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets - Quiver Quantitative

Oct 09, 2025
pulisher
Oct 09, 2025

Pyxis Oncology appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Volume spikes in Pyxis Oncology Inc. stock – what they mean2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What data driven models say about Pyxis Oncology Inc.’s future2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

How institutional ownership impacts Pyxis Oncology Inc. stockMarket Sentiment Review & Daily Momentum Trading Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What to do if you’re stuck in Pyxis Oncology Inc.Trade Risk Summary & Free High Return Stock Watch Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Sector ETF performance correlation with Pyxis Oncology Inc.2025 Investor Takeaways & Low Volatility Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Detecting support and resistance levels for Pyxis Oncology Inc.July 2025 Highlights & Reliable Entry Point Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Wall Street Zen Downgrades Pyxis Oncology (NASDAQ:PYXS) to Sell - Defense World

Oct 05, 2025
pulisher
Oct 04, 2025

Pyxis Oncology (NASDAQ:PYXS) Downgraded to Sell Rating by Wall Street Zen - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Quantitative breakdown of Pyxis Oncology Inc. recent move2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Live market analysis of Pyxis Oncology Inc.July 2025 Intraday Action & Growth Oriented Trade Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can swing trading help recover from Pyxis Oncology Inc. lossesAnalyst Downgrade & Pattern Based Trade Signal System - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Pyxis Oncology, Inc.'s (NASDAQ:PYXS) top owners are retail investors with 39% stake, while 21% is held by institutions - Yahoo Finance

Oct 02, 2025
pulisher
Sep 30, 2025

What analysts say about Pyxis Oncology Inc stockHigh Frequency Trading Trends & Next-Level Stock Intelligence, Now Free - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Sep 30, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):